Why Governance Matters
A dosing decision-support service can be analytically sound and still be unsafe to rely on if nobody has clear authority to approve its use, respond when its operating context changes, or decide when it should stop being used. Governance supplies that authority and the routine for exercising it. It does not replace clinical judgment, validation, or technical controls; it makes responsibility for those activities explicit across the service’s life.
The focus here is accountability: who must answer for a decision and ensure it is made, rather than who performs every task. A modeler may run an analysis, a software engineer may deploy an update, and a pharmacist may assess a recommendation. Those contributions do not, by themselves, establish who has authority to approve the service for a defined clinical use.
A governance arrangement should identify the service and its intended clinical scope, the people or roles with authority at each decision point, the evidence those people must consider, and how decisions and unresolved concerns are recorded. The precise roles and approval steps depend on local clinical, organizational, and regulatory requirements; the framework below is a way to make those requirements operational, not a substitute for them.
Three Interlocking Accountabilities
Clinical, technical, and operational accountabilities answer different questions. They should be connected, but they should not be collapsed into a vague statement that “the team owns the model.”
| Accountability | Core question | Typical decisions and oversight |
|---|---|---|
| Clinical | Is the service appropriate and safe for this defined clinical use? | Approve the intended use and clinical workflow; determine how recommendations are interpreted; set clinical escalation and fallback expectations; review whether continued use remains appropriate. |
| Technical | Does the implemented service continue to behave as an authorized, supportable system? | Oversee the model and software configuration; ensure authorized changes are evaluated; maintain technical support and version identification; advise on technical limitations and serviceability. |
| Operational | Can the service be reliably delivered within the real workflow? | Own staffing, training, access to support, routine monitoring processes, communication of operational changes, and continuity arrangements when normal use is unavailable. |
These are accountability domains, not necessarily three separate departments or three individual job titles. A small organization may assign more than one domain to the same person, provided the assignment is explicit and the person has appropriate authority and competence. Conversely, several specialists may contribute to one domain while a named accountable role ensures the decision is completed.
A practical governance record names an accountable role for each decision, identifies who supplies evidence or performs work, and specifies who must be consulted or informed. It also states what happens if the accountable person is unavailable or if clinical and technical assessments conflict. Titles alone are insufficient: “clinical lead” is ambiguous unless the role’s decision authority and scope are stated.
Decision Rights Across the Service Lifecycle
Governance should follow the service through distinct decision points. Approval is not a one-time permission for every future use. It applies to a specified service version, intended population and setting, workflow, and operating conditions. A material change or a new use may require a new decision under local policy. The earlier material on change control for models and clinical software addresses how changes are controlled; governance identifies who has authority to decide whether a proposed change is acceptable and who oversees the resulting service.
Record the clinical purpose, intended users and patient group, workflow, and boundaries on use. Clinical and operational owners should confirm that the proposed workflow is intelligible and deliverable; technical owners should identify what system is being considered.
Designated decision-makers review relevant validation, data and interface verification, workflow readiness, training, support arrangements, limitations, and fallback plans. Approval should be explicit, scoped, and recorded; silence or completion of technical testing is not approval.
Operational staff carry out assigned checks and route concerns. Clinical and technical accountable roles receive information relevant to their domains and have a defined route to request review or restrict use when concerns arise.
At scheduled review points and when specified triggers occur, accountable roles consider whether the approved scope, supporting evidence, workflow, and operating arrangements remain valid. The outcome is a documented decision: continue, impose conditions, pause, or initiate retirement.
Named authority determines whether the service should be temporarily unavailable or permanently withdrawn, and operations implement the decision with a safe alternative workflow, clear communication, and a record of the effective time and scope.
Each decision should have an evidence basis and a defined route for unresolved issues. For example, if a technical owner cannot support a system component but the clinical owner considers immediate withdrawal disruptive, neither concern should silently override the other. The governance route should identify who convenes the decision, what interim restrictions may be applied, and which authorized role makes the final decision under local policy.
Why Explicit Decision Rights Reduce Risk
The logic is straightforward: a safety-relevant decision requires both adequate information and authority to act on it. If the people who detect a concern cannot escalate it to someone empowered to restrict use, the concern may remain informational rather than protective. If an approver lacks access to relevant evidence, approval cannot reliably reflect the service’s actual condition. Governance connects the two.
A useful check is to trace each important decision from trigger to outcome: who notices that a review is needed, who assembles the evidence, who decides, who implements the decision, and who verifies that implementation occurred. If any link has no named owner or no feasible route, the arrangement is incomplete. This is not a statistical theorem; it is a practical control test for whether a decision can reliably be made and carried through.
Worked Example: Approving a New Hospital Service
Consider a hypothetical hospital preparing a dosing service for a defined adult inpatient population. The model has completed the planned analytical and external validation, and data-pipeline and interface checks are complete. A pilot has also confirmed that pharmacists can review recommendations within the intended workflow. These facts support an approval decision, but they do not establish who may authorize routine use.
The hospital assigns a clinical service lead as accountable for clinical approval, a technical service owner for the deployed model and software, and a pharmacy operations lead for staffing, training, and workflow readiness. A deployment group gathers the evidence and makes a recommendation; it does not replace the designated approvers. The clinical lead confirms the intended population and use boundaries, the technical owner confirms the version and support arrangements, and the operations lead confirms that trained staff and a defined fallback are available.
The launch decision is recorded as approval for the stated population and workflow, conditional on the listed support and monitoring arrangements. It does not authorize use in an unassessed outpatient setting. If any accountable role identifies an unresolved concern within its domain, launch is deferred until the authorized decision-makers resolve it. This is more precise than treating completion of the pilot as automatic permission to go live.
Worked Example: Assigning Ownership After a Workflow Change
In a hypothetical clinic, an operational change moves review of dosing recommendations from a pharmacist to a nurse during part of the day. The model itself and its software version have not changed. The service’s approved workflow and the professional reviewing the recommendation have changed, so the original approval cannot simply be assumed to cover the new arrangement.
The operations lead is responsible for describing the staffing change and identifying when it applies. The clinical accountable role determines whether the new reviewer’s responsibilities, training, escalation route, and use of recommendations remain clinically appropriate. The technical owner checks whether the system configuration or access arrangements also need adjustment. The designated governance authority decides whether the change stays within the approved scope or requires further assessment and approval before implementation.
Suppose the clinical lead determines that the revised review process needs a documented competency check and a direct escalation route before it can be used. The operational lead arranges those steps, and the clinical lead confirms they are in place before authorizing the revised workflow under local policy. This allocation prevents the absence of a software update from being mistaken for evidence that no governance review is needed.
Worked Example: Deciding Whether to Retire a Service
A hypothetical hospital is replacing a dosing service because the underlying platform will no longer receive support after a specified date. A replacement is not yet approved. The technical owner reports the support end date; the operational lead assesses which teams rely on the service and how much time is needed to prepare a fallback; the clinical lead assesses the risk of continued use and the clinical consequences of withdrawal.
The accountable decision-makers distinguish two questions: whether the service remains supportable until the planned end date, and whether it should be withdrawn earlier. They set a review date before support ends and identify a decision deadline that leaves time to communicate and implement the outcome. If support cannot be maintained safely, they can authorize earlier suspension with a defined alternative workflow. If continued use is judged acceptable for a limited period, they record the conditions, scope, and end date rather than treating temporary continuation as indefinite approval.
Retirement is complete only when the authorized withdrawal has been implemented: users have been informed, the service is no longer available for the retired use, and the fallback process is in place. The decision and its effective scope are recorded so later review can distinguish authorized retirement from an unplanned outage.
Review, Escalation, and Failure Modes
A continued-use review is useful only when it can lead to a decision. Governance should define review cadence in a way that reflects local risk and service conditions, while also naming event-based triggers. Examples include a change to the intended population or workflow, loss of a key support capability, repeated operational concerns, or evidence that the assumptions supporting approval may no longer hold. These are prompts for review, not automatic proof that the service is unsafe or must be withdrawn.
The review should consider the service’s current scope and relevant evidence rather than merely confirm that a meeting occurred. Operational monitoring and audit trails can inform the review, but the review’s purpose is to decide what continued use is authorized. If a concern is outside the review group’s authority, the group must know how and to whom to escalate it.
- Unowned decisions: “The project team approves” is inadequate if the team has no named authority or defined membership. Name the accountable role and its scope.
- Task completion mistaken for approval: Passing a validation check or finishing a pilot does not itself authorize routine clinical use. The decision-maker must review the relevant evidence and record a decision.
- One owner for everything: A single service owner may coordinate work, but clinical appropriateness, technical supportability, and operational readiness require explicit consideration. Coordination does not erase domain-specific accountability.
- Reviews without triggers or outcomes: A calendar meeting with no criteria, escalation route, or recorded decision can create the appearance of oversight without an effective control.
- Retirement treated as deletion alone: Removing software without arranging a safe workflow, informing affected users, and specifying when the withdrawal takes effect can leave clinical work unsupported.
Choosing a Governance Structure
A committee can support complex decisions by bringing clinical, technical, and operational perspectives together. It is not automatically the best structure: a committee that lacks delegated authority may only advise, while a single accountable lead can make decisions efficiently but may lack needed perspectives. The key is not organizational form; it is that authority, evidence, consultation, and escalation are clear and proportionate to the service.
A useful governance record can be brief if it answers the essential questions: what service and use are covered; who holds each accountability; who approves launch, continued use, restrictions, and retirement; what evidence is required; what triggers additional review; how conflicts or absence of an owner are handled; and how the decision is communicated and recorded. Local policy may require additional roles or documentation. Governance should align with those requirements rather than create a parallel, conflicting approval route.
The framework also has limits. Clear accountability cannot make weak evidence adequate, guarantee that every concern will be detected, or substitute for competent clinical judgment and maintained technical capability. Nor does assigning one person accountability mean that person must perform every task. The purpose is to make it possible to identify who must ensure a decision is made and who has authority to act on it.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- A validation report is complete, but no role has been assigned to authorize routine use. What governance gap remains?
- A hospital changes who reviews recommendations but makes no change to the software. Why may the change still require governance review?
- Why should a review plan specify event-based triggers as well as scheduled review points?
- What must be addressed for a retirement decision to result in a safe withdrawal rather than merely a software removal?
Solutions. 1. Evidence has been produced, but no authorized decision-maker has been named to assess it and approve a defined clinical use. Completion of validation is not itself approval. 2. The workflow and professional responsibilities can affect how recommendations are interpreted and acted upon; the clinical and operational implications need assessment even if the software version is unchanged. 3. A material concern can arise between scheduled reviews, so triggers provide a route to review when circumstances change rather than waiting for the next calendar date. 4. The accountable roles should authorize the withdrawal and effective scope, communicate it to affected users, arrange a suitable fallback workflow, and ensure the retired service is no longer available for that use.